ArticleScientific reports2024

PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo.

Elizabeth J Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.